Rocket Pharmaceuticals
Rocket Pharmaceuticals Withdraws FDA Application for Rare Blood Disease Gene Therapy
Rocket Pharmaceuticals; FDA; RP-L102; Fanconi Anemia; Gene Therapy; Pipeline Pivot
Actionable Insights Powered by AI
Rocket Pharmaceuticals; FDA; RP-L102; Fanconi Anemia; Gene Therapy; Pipeline Pivot